January 15, 2013
The Story of BiDil: the FDA's First Race-Specific Drug
Hamline University Law Professor Jonathan Kahn has become a prominent critical voice in the last decade on the controversial injection of racial discourse into American medical practice (particularly in the realm of genetically tailored drugs). In the following post, he...